MicroPort CardioFlow Medtech Corporation has announced that it will hold an extraordinary general meeting on December 15, 2025, at its location in Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, China. At the meeting, shareholders will consider and vote on the approval, ratification, and confirmation of the merger agreement dated September 29, 2025, entered into between the company, MicroPort CardioFlow CRM Limited, and MicroPort Cardiac Rhythm Management Limited. The agreement relates to the proposed merger between MicroPort Cardiac Rhythm Management Limited and MicroPort CardioFlow CRM Limited, as well as the transactions contemplated under the merger.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microport Cardioflow Medtech Corporation published the original content used to generate this news brief via via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251125-11926800), on November 24, 2025, and is solely responsible for the information contained therein.